Alafair Biosciences, Inc.
PrivateLast Round
Series B
Apr 18, 2019
Total Funding Raised
$14.26M
Company Overview
Alafair Biosciences, Inc. is a medical device company that develops and commercializes a portfolio of products based on its proprietary hydrogel technology designed to improve patient outcomes by enhancing internal wound healing and protecting soft tissues after surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alafair Biosciences, Inc. Comparables
Compare Alafair Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MAST Biosurgery AG | 83% | |
| FzioMed, Inc. | 81% | |
| Checkpoint Surgical | 79% |
Alafair Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 18, 2019 | ||||
| VC Round | Oct 19, 2018 | ||||
| Convertible Debt | Jul 19, 2017 | ||||
| Series A | Aug 10, 2016 | ||||
| Grant | May 16, 2014 | ||||
Seed | Sep 10, 2013 |
Key People
Founding team and executive leadership
Alafair Biosciences, Inc. Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2025
Ranked #2 on the 2025 Longhorn 100 list.
- Aug 10, 2016
$2M round led by ATP Fund.
Recent news
Latest coverage and updates
- recognized_asAug 11, 2026
Alafair Biosciences, Inc. recognized as 2026 Inc. 5000 on Aug 11th '26.
- launchesJun 30, 2026
Alafair Biosciences, Inc launched VersaCoat Flowable Hydrogel on Jun 30th '26.
Alafair Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alafair Biosciences, Inc.'s valuation, stock price, and market status.
Is Alafair Biosciences, Inc. a public or private company?
Alafair Biosciences, Inc. is a private company.
What is the current stock price of Alafair Biosciences, Inc.?
Alafair Biosciences, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Alafair Biosciences, Inc. worth (valuation)?
Valuation information for Alafair Biosciences, Inc. is not publicly available.
Can I buy Alafair Biosciences, Inc. stock?
Alafair Biosciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alafair Biosciences, Inc.'s last funding round?
Alafair Biosciences, Inc.'s most recent funding round was Series B on April 18, 2019.
Who are the main investors in Alafair Biosciences, Inc.?
Key investors in Alafair Biosciences, Inc. include ATP Fund.
Will Alafair Biosciences, Inc. IPO soon?
No public IPO plans have been announced for Alafair Biosciences, Inc..
How can I track Alafair Biosciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alafair Biosciences, Inc.'s secondary market activity and sign up for updates.